U.S. flag

An official website of the United States government

NM_017780.4(CHD7):c.6070C>T (p.Arg2024Ter) AND Inborn genetic diseases

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 13, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004026047.1

Allele description [Variation Report for NM_017780.4(CHD7):c.6070C>T (p.Arg2024Ter)]

NM_017780.4(CHD7):c.6070C>T (p.Arg2024Ter)

Gene:
CHD7:chromodomain helicase DNA binding protein 7 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
8q12.2
Genomic location:
Preferred name:
NM_017780.4(CHD7):c.6070C>T (p.Arg2024Ter)
HGVS:
  • NC_000008.11:g.60852673C>T
  • NG_007009.1:g.178894C>T
  • NM_001316690.1:c.1717-9556C>T
  • NM_017780.4:c.6070C>TMANE SELECT
  • NP_060250.2:p.Arg2024Ter
  • LRG_176t1:c.6070C>T
  • LRG_176:g.178894C>T
  • NC_000008.10:g.61765232C>T
  • NM_017780.2:c.6070C>T
  • NM_017780.3:c.6070C>T
Protein change:
R2024*
Links:
dbSNP: rs1360515765
NCBI 1000 Genomes Browser:
rs1360515765
Molecular consequence:
  • NM_001316690.1:c.1717-9556C>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_017780.4:c.6070C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004923872Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Nov 13, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations in a new member of the chromodomain gene family cause CHARGE syndrome.

Vissers LE, van Ravenswaaij CM, Admiraal R, Hurst JA, de Vries BB, Janssen IM, van der Vliet WA, Huys EH, de Jong PJ, Hamel BC, Schoenmakers EF, Brunner HG, Veltman JA, van Kessel AG.

Nat Genet. 2004 Sep;36(9):955-7. Epub 2004 Aug 8.

PubMed [citation]
PMID:
15300250

CHD7 mutations in patients initially diagnosed with Kallmann syndrome--the clinical overlap with CHARGE syndrome.

Jongmans MC, van Ravenswaaij-Arts CM, Pitteloud N, Ogata T, Sato N, Claahsen-van der Grinten HL, van der Donk K, Seminara S, Bergman JE, Brunner HG, Crowley WF Jr, Hoefsloot LH.

Clin Genet. 2009 Jan;75(1):65-71. doi: 10.1111/j.1399-0004.2008.01107.x. Epub 2008 Nov 17.

PubMed [citation]
PMID:
19021638
PMCID:
PMC2854009
See all PubMed Citations (5)

Details of each submission

From Ambry Genetics, SCV004923872.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

The c.6070C>T (p.R2024*) alteration, located in exon 30 (coding exon 29) of the CHD7 gene, consists of a C to T substitution at nucleotide position 6070. This changes the amino acid from a arginine (R) to a stop codon at amino acid position 2024. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant has been reported in multiple individuals with features consistent with CHARGE syndrome (Vissers, 2004; Legendre, 2012), including multiple de novo occurrences (Jongmans, 2009; Wessels, 2010; Wu, 2022). Based on the available evidence, this alteration is classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024